Cascade Hemophilia Consortium

What Cascade Hemophilia Consortium does

Cascade Hemophilia Consortium is a non-profit healthcare services organization founded in 1994 and headquartered in Ann Arbor, Michigan. The organization delivers comprehensive care to patients with hemophilia, von Willebrand disease, and related bleeding disorders across a three-state service area covering Michigan, Indiana, and Ohio. Its service portfolio integrates specialty pharmacy dispensing of factor replacement therapies, social work case management, insurance verification and navigation across commercial, Medicaid, Medicare, and state children's programs (CSHCS, ICSHCS, CMH), and patient education delivered via quarterly print newsletters and online resources.

The underlying operating model is built around participation in the federal 340B Drug Pricing Program, which enables Cascade to purchase specialty medications at reduced cost and reinvest the spread into non-billable patient services such as social work and insurance assistance. Technology is operational rather than proprietary: medication management, insurance coordination, recalls handling, and patient forms are managed through conventional healthcare workflows, with a patient payment portal (PayerExpress) for billing. The organization holds ACHC accreditation and is governed by a Board of Directors; Stephanie Raymond serves as Executive Director.

Go-to-market is community-led rather than commercial: patient acquisition relies on healthcare provider referrals, treatment center relationships, community/hemophilia chapter programs, and word-of-mouth within the bleeding disorders community. The customer base is dispersed across individual patients rather than concentrated on institutional buyers, and pricing is not directly disclosed to patients, with costs managed through insurance, patient assistance programs, and 340B savings.

Name

Cascade Hemophilia Consortium

Legal name

Cascade Hemophilia Consortium

Website

https://cascadehc.org

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

Cascade Hemophilia Consortium is a non-profit, 340B-participating healthcare organization founded in 1994 in Ann Arbor, Michigan that delivers specialty pharmacy, social work, and insurance navigation services to patients with hemophilia, von Willebrand disease, and other bleeding disorders across Michigan, Indiana, and Ohio.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy / Bleeding Disorder Care Services

NAICS

Other Individual and Family Services (624190)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Social Services (8300)

akta.pro primary industry

Plasma-Derived Coagulation Factors (Hemophilia Therapies) (HLAIAHAB)

Keywords

• Hemophilia care services
• Specialty pharmacy services
• Bleeding disorder treatment
• Insurance assistance programs
• Nonprofit healthcare consortium

Headquarters

HQ city

Ann Arbor

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Others

Revenue model

1. 340B Pharmacy Program: As a non-profit hemophilia organization, Cascade operates under the 340B Drug Pricing Program, which allows them to purchase specialty medications at reduced costs. Savings from the 340B program support their comprehensive care model, including social work services, insurance assistance, and community support programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Cascade Hemophilia Consortium is a non-profit organization that provides comprehensive care for individuals with hemophilia, von Willebrand Disease, and other bleeding disorders. Its core offering is a coordinated care model combining a 340B specialty pharmacy (dispensing factor replacement and related medications by mail and emergency delivery), insurance verification and navigation across PPO/HMO/Medicaid/Medicare and state programs, social work case management, and patient education resources, delivered to patients across Michigan, Indiana, and Ohio.

Product overview

Cascade Hemophilia Consortium is a non-profit healthcare organization dedicated to enhancing the system of care for people with bleeding disorders. The organization operates as an integrated healthcare services provider offering a coordinated portfolio of services including specialty pharmacy for hemophilia and bleeding disorder medications, insurance assistance programs, social work services, and patient education resources. The core offering centers on the 340B Drug Pricing Program which enables the comprehensive care model. Services span medication dispensing, insurance navigation, and educational support for patients with hemophilia, von Willebrand disease, and related conditions across Michigan, Indiana, and Ohio service areas.

Differentiator

Problem solved

Functional benefit

Products and services

• Hemophilia Care Services
• Specialty Pharmacy Services
• Insurance Assistance Program
• Social Work Services
• Bleeding Disorders Education Resources
• Financial Resources Program
• Hemophilia Chapter Support Programs
• Patient Forms Management
• Recalls Management Service

Quantifiable outcome

• Patients report saving approximately $15,000 per medication shipment
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Bleeding Disorders Substance Use and Mental Health Access Coalition (BD SUMHAC)supportingStrategic or Co-development PartnerCascade references BD SUMHAC as a resource for patients needing access to residential treatment centers for substance use and/or mental health services. This partnership provides additional support services for patients facing co-occurring conditions.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Others

• National Hemophilia Foundation: National patient advocacy and education organization for the bleeding-disorders community; not a pharmacy but adjacent ecosystem participant that influences referrals, education, and policy relevant to Cascade's patients.
• Hemophilia Federation of America: National bleeding-disorder patient advocacy organization; adjacent to Cascade's mission of community-based support and education, and a complementary (not competing) ecosystem partner.

Broad incumbents

• Accredo (Express Scripts specialty pharmacy): Largest U.S. specialty pharmacy operator, including hemophilia factor products; competes with Cascade on payer contracts and patient referrals but at national scale across many therapy areas.
• Option Care Health: National home and alternate-site infusion and specialty pharmacy provider offering bleeding-disorder therapies; broader portfolio than Cascade but directly comparable pharmacy model for factor products.
• CVS Specialty: Specialty pharmacy division of CVS Health offering hemophilia and bleeding-disorder therapies nationally through integrated PBM and retail footprint — broad incumbent competing for the same patient prescriptions.
• Optum Specialty Pharmacy (formerly Diplomat): Specialty pharmacy within Optum (UnitedHealth Group) distributing hemophilia therapies and other high-cost biologics; competes with Cascade via national payer relationships and Carelon integration.

Direct peers

• Hemophilia of Georgia: Regional non-profit hemophilia organization operating a specialty pharmacy and comprehensive care services in Georgia under the same 340B-backed integrated model as Cascade, serving a comparable bleeding-disorder population.
• BioMatrix Specialty Pharmacy: Specialty pharmacy focused on bleeding disorders and other chronic conditions, offering home delivery, clinical support, and insurance coordination — directly comparable to Cascade's core pharmacy-plus-support offering.
• Indiana Hemophilia & Thrombosis Center: Hemophilia treatment center serving patients in Indiana — directly overlapping Cascade's service geography and offering comparable specialty pharmacy and comprehensive care for bleeding disorders.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cascade-hemophilia-consortium

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cascade Hemophilia Consortium